nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—Mitomycin—urinary bladder cancer	0.352	0.505	CbGbCtD
Mannitol—ABCB1—Gemcitabine—urinary bladder cancer	0.101	0.145	CbGbCtD
Mannitol—ABCB1—Cisplatin—urinary bladder cancer	0.0737	0.106	CbGbCtD
Mannitol—ABCB1—Etoposide—urinary bladder cancer	0.0724	0.104	CbGbCtD
Mannitol—ABCB1—Doxorubicin—urinary bladder cancer	0.0494	0.0708	CbGbCtD
Mannitol—ABCB1—Methotrexate—urinary bladder cancer	0.0478	0.0686	CbGbCtD
Mannitol—Tachycardia—Cisplatin—urinary bladder cancer	0.000392	0.00129	CcSEcCtD
Mannitol—Convulsion—Etoposide—urinary bladder cancer	0.000391	0.00129	CcSEcCtD
Mannitol—Dehydration—Epirubicin—urinary bladder cancer	0.000391	0.00129	CcSEcCtD
Mannitol—Skin disorder—Cisplatin—urinary bladder cancer	0.000391	0.00129	CcSEcCtD
Mannitol—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.00039	0.00129	CcSEcCtD
Mannitol—Hypertension—Etoposide—urinary bladder cancer	0.00039	0.00129	CcSEcCtD
Mannitol—Pain in extremity—Doxorubicin—urinary bladder cancer	0.000389	0.00128	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000386	0.00127	CcSEcCtD
Mannitol—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000385	0.00127	CcSEcCtD
Mannitol—Chest pain—Etoposide—urinary bladder cancer	0.000384	0.00127	CcSEcCtD
Mannitol—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000384	0.00127	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000382	0.00126	CcSEcCtD
Mannitol—Discomfort—Etoposide—urinary bladder cancer	0.00038	0.00125	CcSEcCtD
Mannitol—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000378	0.00125	CcSEcCtD
Mannitol—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000378	0.00125	CcSEcCtD
Mannitol—Hypotension—Cisplatin—urinary bladder cancer	0.000376	0.00124	CcSEcCtD
Mannitol—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000376	0.00124	CcSEcCtD
Mannitol—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000375	0.00124	CcSEcCtD
Mannitol—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000372	0.00123	CcSEcCtD
Mannitol—Fatigue—Gemcitabine—urinary bladder cancer	0.000372	0.00123	CcSEcCtD
Mannitol—Pain—Gemcitabine—urinary bladder cancer	0.000369	0.00122	CcSEcCtD
Mannitol—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000369	0.00122	CcSEcCtD
Mannitol—Asthenia—Thiotepa—urinary bladder cancer	0.000368	0.00121	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000366	0.00121	CcSEcCtD
Mannitol—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000366	0.00121	CcSEcCtD
Mannitol—Infection—Etoposide—urinary bladder cancer	0.000366	0.00121	CcSEcCtD
Mannitol—Pruritus—Thiotepa—urinary bladder cancer	0.000363	0.0012	CcSEcCtD
Mannitol—Pain—Fluorouracil—urinary bladder cancer	0.000363	0.0012	CcSEcCtD
Mannitol—Dehydration—Doxorubicin—urinary bladder cancer	0.000361	0.00119	CcSEcCtD
Mannitol—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000361	0.00119	CcSEcCtD
Mannitol—Tachycardia—Etoposide—urinary bladder cancer	0.000359	0.00119	CcSEcCtD
Mannitol—Dyspnoea—Cisplatin—urinary bladder cancer	0.000358	0.00118	CcSEcCtD
Mannitol—Skin disorder—Etoposide—urinary bladder cancer	0.000358	0.00118	CcSEcCtD
Mannitol—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000355	0.00117	CcSEcCtD
Mannitol—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000355	0.00117	CcSEcCtD
Mannitol—Angina pectoris—Epirubicin—urinary bladder cancer	0.000354	0.00117	CcSEcCtD
Mannitol—Diarrhoea—Thiotepa—urinary bladder cancer	0.000351	0.00116	CcSEcCtD
Mannitol—Decreased appetite—Cisplatin—urinary bladder cancer	0.000349	0.00115	CcSEcCtD
Mannitol—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000349	0.00115	CcSEcCtD
Mannitol—Bronchitis—Epirubicin—urinary bladder cancer	0.000349	0.00115	CcSEcCtD
Mannitol—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000348	0.00115	CcSEcCtD
Mannitol—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000347	0.00114	CcSEcCtD
Mannitol—Infestation NOS—Methotrexate—urinary bladder cancer	0.000346	0.00114	CcSEcCtD
Mannitol—Infestation—Methotrexate—urinary bladder cancer	0.000346	0.00114	CcSEcCtD
Mannitol—Hypotension—Etoposide—urinary bladder cancer	0.000344	0.00114	CcSEcCtD
Mannitol—Pain—Cisplatin—urinary bladder cancer	0.000344	0.00113	CcSEcCtD
Mannitol—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000341	0.00112	CcSEcCtD
Mannitol—Renal failure—Methotrexate—urinary bladder cancer	0.00034	0.00112	CcSEcCtD
Mannitol—Dizziness—Thiotepa—urinary bladder cancer	0.000339	0.00112	CcSEcCtD
Mannitol—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000337	0.00111	CcSEcCtD
Mannitol—Stomatitis—Methotrexate—urinary bladder cancer	0.000337	0.00111	CcSEcCtD
Mannitol—Urticaria—Fluorouracil—urinary bladder cancer	0.000337	0.00111	CcSEcCtD
Mannitol—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000335	0.00111	CcSEcCtD
Mannitol—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000331	0.00109	CcSEcCtD
Mannitol—Dyspnoea—Etoposide—urinary bladder cancer	0.000328	0.00108	CcSEcCtD
Mannitol—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000327	0.00108	CcSEcCtD
Mannitol—Vomiting—Thiotepa—urinary bladder cancer	0.000326	0.00108	CcSEcCtD
Mannitol—Infestation NOS—Epirubicin—urinary bladder cancer	0.000324	0.00107	CcSEcCtD
Mannitol—Infestation—Epirubicin—urinary bladder cancer	0.000324	0.00107	CcSEcCtD
Mannitol—Rash—Thiotepa—urinary bladder cancer	0.000323	0.00107	CcSEcCtD
Mannitol—Bronchitis—Doxorubicin—urinary bladder cancer	0.000323	0.00107	CcSEcCtD
Mannitol—Dermatitis—Thiotepa—urinary bladder cancer	0.000323	0.00107	CcSEcCtD
Mannitol—Headache—Thiotepa—urinary bladder cancer	0.000321	0.00106	CcSEcCtD
Mannitol—Decreased appetite—Etoposide—urinary bladder cancer	0.00032	0.00106	CcSEcCtD
Mannitol—Renal failure—Epirubicin—urinary bladder cancer	0.000318	0.00105	CcSEcCtD
Mannitol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000318	0.00105	CcSEcCtD
Mannitol—Body temperature increased—Cisplatin—urinary bladder cancer	0.000318	0.00105	CcSEcCtD
Mannitol—Fatigue—Etoposide—urinary bladder cancer	0.000318	0.00105	CcSEcCtD
Mannitol—Stomatitis—Epirubicin—urinary bladder cancer	0.000316	0.00104	CcSEcCtD
Mannitol—Pain—Etoposide—urinary bladder cancer	0.000315	0.00104	CcSEcCtD
Mannitol—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000312	0.00103	CcSEcCtD
Mannitol—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000312	0.00103	CcSEcCtD
Mannitol—Asthenia—Gemcitabine—urinary bladder cancer	0.000309	0.00102	CcSEcCtD
Mannitol—Pharyngitis—Methotrexate—urinary bladder cancer	0.000308	0.00102	CcSEcCtD
Mannitol—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000307	0.00101	CcSEcCtD
Mannitol—Pruritus—Gemcitabine—urinary bladder cancer	0.000305	0.00101	CcSEcCtD
Mannitol—Nausea—Thiotepa—urinary bladder cancer	0.000305	0.001	CcSEcCtD
Mannitol—Urethral disorder—Methotrexate—urinary bladder cancer	0.000304	0.001	CcSEcCtD
Mannitol—Feeling abnormal—Etoposide—urinary bladder cancer	0.000304	0.001	CcSEcCtD
Mannitol—Pruritus—Fluorouracil—urinary bladder cancer	0.0003	0.00099	CcSEcCtD
Mannitol—Infestation NOS—Doxorubicin—urinary bladder cancer	0.0003	0.000988	CcSEcCtD
Mannitol—Infestation—Doxorubicin—urinary bladder cancer	0.0003	0.000988	CcSEcCtD
Mannitol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000296	0.000977	CcSEcCtD
Mannitol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000295	0.000973	CcSEcCtD
Mannitol—Renal failure—Doxorubicin—urinary bladder cancer	0.000294	0.000971	CcSEcCtD
Mannitol—Urticaria—Etoposide—urinary bladder cancer	0.000293	0.000965	CcSEcCtD
Mannitol—Stomatitis—Doxorubicin—urinary bladder cancer	0.000292	0.000963	CcSEcCtD
Mannitol—Rhinitis—Epirubicin—urinary bladder cancer	0.000291	0.000961	CcSEcCtD
Mannitol—Body temperature increased—Etoposide—urinary bladder cancer	0.000291	0.00096	CcSEcCtD
Mannitol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00029	0.000957	CcSEcCtD
Mannitol—Asthenia—Cisplatin—urinary bladder cancer	0.000288	0.000951	CcSEcCtD
Mannitol—Pharyngitis—Epirubicin—urinary bladder cancer	0.000288	0.000951	CcSEcCtD
Mannitol—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000287	0.000947	CcSEcCtD
Mannitol—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000286	0.000942	CcSEcCtD
Mannitol—Urethral disorder—Epirubicin—urinary bladder cancer	0.000285	0.00094	CcSEcCtD
Mannitol—Dizziness—Fluorouracil—urinary bladder cancer	0.00028	0.000925	CcSEcCtD
Mannitol—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00028	0.000923	CcSEcCtD
Mannitol—Chills—Methotrexate—urinary bladder cancer	0.000279	0.000919	CcSEcCtD
Mannitol—Diarrhoea—Cisplatin—urinary bladder cancer	0.000275	0.000907	CcSEcCtD
Mannitol—Vomiting—Gemcitabine—urinary bladder cancer	0.000274	0.000905	CcSEcCtD
Mannitol—Mental disorder—Methotrexate—urinary bladder cancer	0.000272	0.000897	CcSEcCtD
Mannitol—Rash—Gemcitabine—urinary bladder cancer	0.000272	0.000897	CcSEcCtD
Mannitol—Dermatitis—Gemcitabine—urinary bladder cancer	0.000272	0.000896	CcSEcCtD
Mannitol—Hypersensitivity—Etoposide—urinary bladder cancer	0.000271	0.000895	CcSEcCtD
Mannitol—Malnutrition—Methotrexate—urinary bladder cancer	0.00027	0.000892	CcSEcCtD
Mannitol—Headache—Gemcitabine—urinary bladder cancer	0.00027	0.000891	CcSEcCtD
Mannitol—Vomiting—Fluorouracil—urinary bladder cancer	0.00027	0.000889	CcSEcCtD
Mannitol—Rhinitis—Doxorubicin—urinary bladder cancer	0.00027	0.000889	CcSEcCtD
Mannitol—Rash—Fluorouracil—urinary bladder cancer	0.000267	0.000882	CcSEcCtD
Mannitol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000267	0.000881	CcSEcCtD
Mannitol—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000267	0.00088	CcSEcCtD
Mannitol—Headache—Fluorouracil—urinary bladder cancer	0.000266	0.000876	CcSEcCtD
Mannitol—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000266	0.000876	CcSEcCtD
Mannitol—Asthenia—Etoposide—urinary bladder cancer	0.000264	0.000872	CcSEcCtD
Mannitol—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000264	0.000872	CcSEcCtD
Mannitol—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000264	0.000869	CcSEcCtD
Mannitol—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000262	0.000864	CcSEcCtD
Mannitol—Back pain—Methotrexate—urinary bladder cancer	0.000261	0.000862	CcSEcCtD
Mannitol—Chills—Epirubicin—urinary bladder cancer	0.000261	0.00086	CcSEcCtD
Mannitol—Pruritus—Etoposide—urinary bladder cancer	0.000261	0.00086	CcSEcCtD
Mannitol—Nausea—Gemcitabine—urinary bladder cancer	0.000256	0.000845	CcSEcCtD
Mannitol—Vomiting—Cisplatin—urinary bladder cancer	0.000256	0.000843	CcSEcCtD
Mannitol—Vision blurred—Methotrexate—urinary bladder cancer	0.000255	0.00084	CcSEcCtD
Mannitol—Mental disorder—Epirubicin—urinary bladder cancer	0.000255	0.00084	CcSEcCtD
Mannitol—Rash—Cisplatin—urinary bladder cancer	0.000253	0.000836	CcSEcCtD
Mannitol—Dermatitis—Cisplatin—urinary bladder cancer	0.000253	0.000835	CcSEcCtD
Mannitol—Malnutrition—Epirubicin—urinary bladder cancer	0.000253	0.000834	CcSEcCtD
Mannitol—Diarrhoea—Etoposide—urinary bladder cancer	0.000252	0.000831	CcSEcCtD
Mannitol—Nausea—Fluorouracil—urinary bladder cancer	0.000252	0.000831	CcSEcCtD
Mannitol—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000251	0.000827	CcSEcCtD
Mannitol—Flatulence—Epirubicin—urinary bladder cancer	0.000249	0.000822	CcSEcCtD
Mannitol—Nervousness—Epirubicin—urinary bladder cancer	0.000246	0.00081	CcSEcCtD
Mannitol—Back pain—Epirubicin—urinary bladder cancer	0.000245	0.000807	CcSEcCtD
Mannitol—Malaise—Methotrexate—urinary bladder cancer	0.000244	0.000804	CcSEcCtD
Mannitol—Dizziness—Etoposide—urinary bladder cancer	0.000244	0.000803	CcSEcCtD
Mannitol—Vertigo—Methotrexate—urinary bladder cancer	0.000243	0.000801	CcSEcCtD
Mannitol—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000242	0.000799	CcSEcCtD
Mannitol—Chills—Doxorubicin—urinary bladder cancer	0.000241	0.000796	CcSEcCtD
Mannitol—Nausea—Cisplatin—urinary bladder cancer	0.000239	0.000788	CcSEcCtD
Mannitol—Vision blurred—Epirubicin—urinary bladder cancer	0.000238	0.000786	CcSEcCtD
Mannitol—Cough—Methotrexate—urinary bladder cancer	0.000236	0.000778	CcSEcCtD
Mannitol—Mental disorder—Doxorubicin—urinary bladder cancer	0.000236	0.000777	CcSEcCtD
Mannitol—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000235	0.000774	CcSEcCtD
Mannitol—Convulsion—Methotrexate—urinary bladder cancer	0.000234	0.000773	CcSEcCtD
Mannitol—Vomiting—Etoposide—urinary bladder cancer	0.000234	0.000772	CcSEcCtD
Mannitol—Malnutrition—Doxorubicin—urinary bladder cancer	0.000234	0.000772	CcSEcCtD
Mannitol—Rash—Etoposide—urinary bladder cancer	0.000232	0.000766	CcSEcCtD
Mannitol—Dermatitis—Etoposide—urinary bladder cancer	0.000232	0.000765	CcSEcCtD
Mannitol—Headache—Etoposide—urinary bladder cancer	0.000231	0.000761	CcSEcCtD
Mannitol—Flatulence—Doxorubicin—urinary bladder cancer	0.000231	0.000761	CcSEcCtD
Mannitol—Chest pain—Methotrexate—urinary bladder cancer	0.00023	0.000759	CcSEcCtD
Mannitol—Arthralgia—Methotrexate—urinary bladder cancer	0.00023	0.000759	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000229	0.000754	CcSEcCtD
Mannitol—Malaise—Epirubicin—urinary bladder cancer	0.000228	0.000752	CcSEcCtD
Mannitol—Discomfort—Methotrexate—urinary bladder cancer	0.000227	0.00075	CcSEcCtD
Mannitol—Nervousness—Doxorubicin—urinary bladder cancer	0.000227	0.00075	CcSEcCtD
Mannitol—Vertigo—Epirubicin—urinary bladder cancer	0.000227	0.00075	CcSEcCtD
Mannitol—Back pain—Doxorubicin—urinary bladder cancer	0.000226	0.000747	CcSEcCtD
Mannitol—Cough—Epirubicin—urinary bladder cancer	0.000221	0.000728	CcSEcCtD
Mannitol—Vision blurred—Doxorubicin—urinary bladder cancer	0.000221	0.000728	CcSEcCtD
Mannitol—Convulsion—Epirubicin—urinary bladder cancer	0.000219	0.000723	CcSEcCtD
Mannitol—Infection—Methotrexate—urinary bladder cancer	0.000219	0.000723	CcSEcCtD
Mannitol—Nausea—Etoposide—urinary bladder cancer	0.000219	0.000722	CcSEcCtD
Mannitol—Hypertension—Epirubicin—urinary bladder cancer	0.000218	0.00072	CcSEcCtD
Mannitol—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000217	0.000716	CcSEcCtD
Mannitol—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000216	0.000714	CcSEcCtD
Mannitol—Chest pain—Epirubicin—urinary bladder cancer	0.000215	0.00071	CcSEcCtD
Mannitol—Arthralgia—Epirubicin—urinary bladder cancer	0.000215	0.00071	CcSEcCtD
Mannitol—Skin disorder—Methotrexate—urinary bladder cancer	0.000214	0.000707	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000214	0.000706	CcSEcCtD
Mannitol—Discomfort—Epirubicin—urinary bladder cancer	0.000213	0.000702	CcSEcCtD
Mannitol—Malaise—Doxorubicin—urinary bladder cancer	0.000211	0.000696	CcSEcCtD
Mannitol—Vertigo—Doxorubicin—urinary bladder cancer	0.00021	0.000694	CcSEcCtD
Mannitol—Oedema—Epirubicin—urinary bladder cancer	0.000206	0.000681	CcSEcCtD
Mannitol—Hypotension—Methotrexate—urinary bladder cancer	0.000206	0.00068	CcSEcCtD
Mannitol—Infection—Epirubicin—urinary bladder cancer	0.000205	0.000677	CcSEcCtD
Mannitol—Cough—Doxorubicin—urinary bladder cancer	0.000204	0.000674	CcSEcCtD
Mannitol—Convulsion—Doxorubicin—urinary bladder cancer	0.000203	0.000669	CcSEcCtD
Mannitol—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000202	0.000668	CcSEcCtD
Mannitol—Hypertension—Doxorubicin—urinary bladder cancer	0.000202	0.000667	CcSEcCtD
Mannitol—Tachycardia—Epirubicin—urinary bladder cancer	0.000201	0.000665	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000201	0.000663	CcSEcCtD
Mannitol—Skin disorder—Epirubicin—urinary bladder cancer	0.000201	0.000661	CcSEcCtD
Mannitol—Chest pain—Doxorubicin—urinary bladder cancer	0.000199	0.000657	CcSEcCtD
Mannitol—Arthralgia—Doxorubicin—urinary bladder cancer	0.000199	0.000657	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000198	0.000653	CcSEcCtD
Mannitol—Discomfort—Doxorubicin—urinary bladder cancer	0.000197	0.000649	CcSEcCtD
Mannitol—Dyspnoea—Methotrexate—urinary bladder cancer	0.000197	0.000649	CcSEcCtD
Mannitol—Hypotension—Epirubicin—urinary bladder cancer	0.000193	0.000636	CcSEcCtD
Mannitol—Decreased appetite—Methotrexate—urinary bladder cancer	0.000192	0.000633	CcSEcCtD
Mannitol—Oedema—Doxorubicin—urinary bladder cancer	0.000191	0.00063	CcSEcCtD
Mannitol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00019	0.000628	CcSEcCtD
Mannitol—Fatigue—Methotrexate—urinary bladder cancer	0.00019	0.000627	CcSEcCtD
Mannitol—Infection—Doxorubicin—urinary bladder cancer	0.00019	0.000626	CcSEcCtD
Mannitol—Pain—Methotrexate—urinary bladder cancer	0.000189	0.000622	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000188	0.00062	CcSEcCtD
Mannitol—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000187	0.000618	CcSEcCtD
Mannitol—Tachycardia—Doxorubicin—urinary bladder cancer	0.000186	0.000615	CcSEcCtD
Mannitol—Skin disorder—Doxorubicin—urinary bladder cancer	0.000186	0.000612	CcSEcCtD
Mannitol—Dyspnoea—Epirubicin—urinary bladder cancer	0.000184	0.000607	CcSEcCtD
Mannitol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000182	0.0006	CcSEcCtD
Mannitol—Decreased appetite—Epirubicin—urinary bladder cancer	0.000179	0.000592	CcSEcCtD
Mannitol—Hypotension—Doxorubicin—urinary bladder cancer	0.000179	0.000589	CcSEcCtD
Mannitol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000178	0.000588	CcSEcCtD
Mannitol—Fatigue—Epirubicin—urinary bladder cancer	0.000178	0.000587	CcSEcCtD
Mannitol—Pain—Epirubicin—urinary bladder cancer	0.000177	0.000582	CcSEcCtD
Mannitol—Urticaria—Methotrexate—urinary bladder cancer	0.000175	0.000578	CcSEcCtD
Mannitol—Body temperature increased—Methotrexate—urinary bladder cancer	0.000174	0.000575	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000174	0.000574	CcSEcCtD
Mannitol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00017	0.000562	CcSEcCtD
Mannitol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00017	0.000561	CcSEcCtD
Mannitol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000166	0.000548	CcSEcCtD
Mannitol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000165	0.000544	CcSEcCtD
Mannitol—Fatigue—Doxorubicin—urinary bladder cancer	0.000165	0.000543	CcSEcCtD
Mannitol—Urticaria—Epirubicin—urinary bladder cancer	0.000164	0.000541	CcSEcCtD
Mannitol—Pain—Doxorubicin—urinary bladder cancer	0.000163	0.000539	CcSEcCtD
Mannitol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000163	0.000538	CcSEcCtD
Mannitol—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000163	0.000536	CcSEcCtD
Mannitol—Asthenia—Methotrexate—urinary bladder cancer	0.000158	0.000522	CcSEcCtD
Mannitol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000157	0.000519	CcSEcCtD
Mannitol—Pruritus—Methotrexate—urinary bladder cancer	0.000156	0.000515	CcSEcCtD
Mannitol—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000152	0.000502	CcSEcCtD
Mannitol—Urticaria—Doxorubicin—urinary bladder cancer	0.000152	0.000501	CcSEcCtD
Mannitol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000151	0.000498	CcSEcCtD
Mannitol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000151	0.000498	CcSEcCtD
Mannitol—Asthenia—Epirubicin—urinary bladder cancer	0.000148	0.000489	CcSEcCtD
Mannitol—Pruritus—Epirubicin—urinary bladder cancer	0.000146	0.000482	CcSEcCtD
Mannitol—Dizziness—Methotrexate—urinary bladder cancer	0.000146	0.000481	CcSEcCtD
Mannitol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000141	0.000466	CcSEcCtD
Mannitol—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000141	0.000464	CcSEcCtD
Mannitol—Vomiting—Methotrexate—urinary bladder cancer	0.00014	0.000463	CcSEcCtD
Mannitol—Rash—Methotrexate—urinary bladder cancer	0.000139	0.000459	CcSEcCtD
Mannitol—Dermatitis—Methotrexate—urinary bladder cancer	0.000139	0.000458	CcSEcCtD
Mannitol—Headache—Methotrexate—urinary bladder cancer	0.000138	0.000456	CcSEcCtD
Mannitol—Asthenia—Doxorubicin—urinary bladder cancer	0.000137	0.000452	CcSEcCtD
Mannitol—Dizziness—Epirubicin—urinary bladder cancer	0.000137	0.00045	CcSEcCtD
Mannitol—Pruritus—Doxorubicin—urinary bladder cancer	0.000135	0.000446	CcSEcCtD
Mannitol—Vomiting—Epirubicin—urinary bladder cancer	0.000131	0.000433	CcSEcCtD
Mannitol—Nausea—Methotrexate—urinary bladder cancer	0.000131	0.000432	CcSEcCtD
Mannitol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000131	0.000431	CcSEcCtD
Mannitol—Rash—Epirubicin—urinary bladder cancer	0.00013	0.000429	CcSEcCtD
Mannitol—Dermatitis—Epirubicin—urinary bladder cancer	0.00013	0.000429	CcSEcCtD
Mannitol—Headache—Epirubicin—urinary bladder cancer	0.000129	0.000427	CcSEcCtD
Mannitol—Dizziness—Doxorubicin—urinary bladder cancer	0.000126	0.000417	CcSEcCtD
Mannitol—Nausea—Epirubicin—urinary bladder cancer	0.000123	0.000405	CcSEcCtD
Mannitol—Vomiting—Doxorubicin—urinary bladder cancer	0.000121	0.000401	CcSEcCtD
Mannitol—Rash—Doxorubicin—urinary bladder cancer	0.00012	0.000397	CcSEcCtD
Mannitol—Dermatitis—Doxorubicin—urinary bladder cancer	0.00012	0.000397	CcSEcCtD
Mannitol—Headache—Doxorubicin—urinary bladder cancer	0.00012	0.000395	CcSEcCtD
Mannitol—Nausea—Doxorubicin—urinary bladder cancer	0.000113	0.000374	CcSEcCtD
